Search Results 1041-1050 of 6664 for 谷歌搜索留痕工具咨询邮箱：lgooxc@hotmail.com
Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This is a safety study to compare the safety of receiving a lung treated with the Toronto EVLP System™ by SPONSOR in SPONSOR's dedicated facility against ...
The aim of this study is to measure the differences in quality of life and mood of liver transplant recipients in the immediate month post- transplant staying ...
The Center for Cell Signaling in Gastroenterology at Mayo Clinic includes faculty members with expertise in biochemistry, molecular biology, endocrinology, ...
The purpose of this study is to determine the efficacy of frexalimab in delaying the disability progression and the safety up to approximately 51 months ...
The purpose of this study is to develope a rapid lab test for counting total bacteria in human intestinal fluid collected by aspiration from the duodenal ...
The purpose of this study is to leverage the Jax Saludable Community-Academic partnership and the expertise of our community co-lead, the HOPE2 Advisory Board, ...
About this study. Capsular REpair randomiSed controlled Trial (CREST) is a multi-center, randomized controlled trial with a sample size of 240 patients (120 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.